Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer
Authors:
- S MassazzaSMS Massazza
- M CilliMCM Cilli
- L VaresioLVL Varesio
- M C BoscoM C Bosco
- 1 March 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (6) , 431-441
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 37 references indexed in Scilit:
- Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivoGene Therapy, 2000
- Transduction of glioma cells using a high-titer retroviral vector system and their subsequent migration in brain tumorsGene Therapy, 1998
- Green Fluorescent Protein Retroviral Vectors: Low Titer and High Recombination Frequency Suggest a Selective DisadvantageHuman Gene Therapy, 1997
- Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovirCancer Letters, 1995
- Retroviral Vectors for Use in Human Gene Therapy for Cancer, Gaucher Disease, and ArthritisaAnnals of the New York Academy of Sciences, 1994
- Retrovirus-mediated gene transfer in cancer therapyPharmacology & Therapeutics, 1994
- An experimental model of retrovirus gene therapy for malignant brain tumorsJournal of Neurosurgery, 1993
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Immortalization of macrophages from mouse bone marrow and fetal liverExperimental Cell Research, 1990
- Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirusNature, 1985